LB Pharmaceuticals Inc Common Stock (NASDAQ: LBRX) is a Healthcare company (Biotechnology) with a market capitalization of $1.4B. The Maz Rating grades it against the other companies in its sector.
LB Pharmaceuticals Inc Common Stock's current Maz Rating and its five factor grades are for members: log in to see them.
At $43.01, LB Pharmaceuticals Inc Common Stock trades at 3.4x book value. It runs a gross margin of 0.0%, an operating margin of 0.0% and a net margin of 0.0%. It shows return on equity of -39.5%, return on invested capital of -35.9% and a free cash flow yield of -10.3%. On the balance sheet: a debt-to-equity ratio of 0.01 and a current ratio of 14.78. Over the past 52 weeks the share price ranged from $15.13 to $50.16, with a beta of 0.42.
LB Pharmaceuticals Inc Common Stock does not currently pay a dividend.
4 Wall Street analyst ratings cover the stock: 3 Buy and 1 Hold, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.